Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-Term Outcomes of a Self-Expanding Transcatheter Heart Valve.

Structural heart : the journal of the Heart Team·2026
Same author

Balloon-Expandable Versus Self-Expanding Valves in Patients With Small Aortic Annuli Undergoing Transcatheter Aortic Valve Replacement.

The American journal of cardiology·2026
Same author

In-hospital outcomes of valve-in-valve vs. native valve transcatheter aortic valve implantation in Brazil: A propensity-matched analysis.

International journal of cardiology·2026
Same author

Polymer-free sirolimus-based submicron carrier-eluting stent: present and future perspective.

Expert review of medical devices·2026
Same author

Acute ST-Segment Elevation Myocardial Infarction Secondary to Neoplastic Infiltration of the Left Anterior Descending Artery.

JACC. Case reports·2026
Same author

Sex-Based Outcomes in Patients With High Bleeding Risk After PCI With 1-Month DAPT: Results From the Onyx ONE Clear Study.

Journal of the Society for Cardiovascular Angiography & Interventions·2026

Related Experiment Video

Updated: May 4, 2026

Author Spotlight: Insights into the Use of Apple-Derived Cellulose Scaffolds for Bone Tissue Engineering
09:49

Author Spotlight: Insights into the Use of Apple-Derived Cellulose Scaffolds for Bone Tissue Engineering

Published on: February 23, 2024

2.8K

Bioresorbable scaffolds: rationale, current status, challenges, and future.

Javaid Iqbal1, Yoshinobu Onuma, John Ormiston

  • 1Thorax Centre, Erasmus Medical Centre, Rotterdam, the Netherlands.

European Heart Journal
|December 25, 2013
PubMed
Summary
This summary is machine-generated.

Bioresorbable scaffolds offer a promising alternative to traditional drug-eluting stents by temporarily supporting arteries and then disappearing. This approach aims to restore natural vessel function and overcome limitations of permanent metallic implants.

Keywords:
Bioresorbable scaffoldsCoronary angioplastyDrug-eluting stents

More Related Videos

Distinctive Capillary Action by Micro-channels in Bone-like Templates can Enhance Recruitment of Cells for Restoration of Large Bony Defect
09:35

Distinctive Capillary Action by Micro-channels in Bone-like Templates can Enhance Recruitment of Cells for Restoration of Large Bony Defect

Published on: September 11, 2015

10.8K
Novel Process for 3D Printing Decellularized Matrices
08:14

Novel Process for 3D Printing Decellularized Matrices

Published on: January 7, 2019

6.6K

Related Experiment Videos

Last Updated: May 4, 2026

Author Spotlight: Insights into the Use of Apple-Derived Cellulose Scaffolds for Bone Tissue Engineering
09:49

Author Spotlight: Insights into the Use of Apple-Derived Cellulose Scaffolds for Bone Tissue Engineering

Published on: February 23, 2024

2.8K
Distinctive Capillary Action by Micro-channels in Bone-like Templates can Enhance Recruitment of Cells for Restoration of Large Bony Defect
09:35

Distinctive Capillary Action by Micro-channels in Bone-like Templates can Enhance Recruitment of Cells for Restoration of Large Bony Defect

Published on: September 11, 2015

10.8K
Novel Process for 3D Printing Decellularized Matrices
08:14

Novel Process for 3D Printing Decellularized Matrices

Published on: January 7, 2019

6.6K

Area of Science:

  • Cardiovascular Medicine
  • Biomaterials Science
  • Interventional Cardiology

Background:

  • Drug-eluting stents (DES) have reduced restenosis and thrombosis after percutaneous coronary intervention.
  • Permanent metallic stents pose risks including inflammation, neoatherosclerosis, and impaired vascular function.
  • DES limit future treatment options like grafting due to their permanent nature.

Purpose of the Study:

  • To review the current status of bioresorbable scaffolds (BRSs) in coronary intervention.
  • To evaluate the potential of BRSs to overcome limitations associated with permanent metallic stents.
  • To identify challenges hindering widespread adoption of BRSs.

Main Methods:

  • Review of current literature and clinical data on available BRS devices.
  • Analysis of the advantages and disadvantages of BRSs compared to DES.
  • Evaluation of regulatory status and clinical trial outcomes for leading BRS technologies.

Main Results:

  • BRSs provide temporary scaffolding, potentially restoring vessel pulsatility and physiological function.
  • Two BRS devices have achieved Conformité Européenne (CE) marking, indicating significant clinical data.
  • BRSs aim to eliminate the long-term risks associated with permanent metallic stent implantation.

Conclusions:

  • BRSs represent a significant advancement, offering a potential solution to the limitations of permanent DES.
  • Further research and clinical evaluation are necessary to establish BRSs as a primary treatment modality.
  • Overcoming current challenges is crucial for BRSs to become the standard of care in coronary interventions.